PUBLISHER: Polaris Market Research | PRODUCT CODE: 1652108
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1652108
The global sacral nerve stimulation market size is expected to reach USD 5,334.82 million by 2034, according to a new study by Polaris Market Research. The report "Sacral Nerve Stimulation Market Size, Share, Trends, Industry Analysis Report: By Product Type (Devices and Accessories), Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The sacral nerve stimulation market is experiencing significant growth due to advancements in technology that enhance device effectiveness and affordability. Increased sophistication and cost-effectiveness of sacral nerve stimulation devices are likely to drive higher adoption rates among healthcare providers and patients. For instance, Medtronic's launch of the InterStim Micro Rechargeable Sacral Neuromodulation System in August 2020 shows innovation in this field, offering better performance and patient convenience. These developments expand treatment options and boost patient confidence, thereby contributing to the market growth.
The sacral nerve stimulation market is expanding due to the rising adoption of minimally invasive procedures. For instance, according to the National Library of Medicine, minimally invasive procedures currently have an adoption rate of 80% to 90%. Patients and healthcare providers increasingly prefer less invasive options that offer quicker recovery and fewer complications. This shift in preference has increased the demand for sacral nerve stimulation as an appealing treatment for urinary and fecal incontinence, positively impacting the market expansion.
Rising healthcare expenditure, as a percentage of GDP, is driving the demand for sacral nerve stimulators. This has led to increased investment in advanced medical technologies, enhancing patient care and treatment options for conditions like urinary and fecal incontinence.
Based on product type, the device segment is anticipated to experience substantial growth with a significant CAGR in the global market. This growth is attributed to an increase in the adoption of new devices due to miniaturization and enhanced functionality.
Based on end user, the hospitals segment is expected to dominate the global market in the forecasted years, driven by the increase in hospital admissions and extended hospital stays.
In 2024, North America dominated the global sacral nerve stimulation market due to the increasing number of hospitals in the region.
The sacral nerve stimulation market in Germany is projected for substantial growth due to increasing government expenditure on healthcare.
A few of the global key market players are Saluda Medical Pty Ltd.; Medtronic plc; Beijing PINS Medical Co., Ltd.; Axonics, Inc.; Boston Scientific Corporation; Nervo Corp.; Stimwave Technologies Inc.; St. Jude Medical; and Congentix Medical.
Polaris Market Research has segmented the sacral nerve stimulation market research report on the basis of product type, application, end user, and region: